Fig. 7From: Integrated investigation and discovery of therapeutic targets for 3-hydroxybakuchiol against diabetes based on molecular docking studies and cell experimentsMolecular docking results of HYD with core targets. AÂ HYD-AKT1; BÂ HYD-HSP90AA1; CÂ HYD-MAPK1; DÂ HYD-SRCBack to article page